Semaglutide

Semaglutide is a GLP-1 receptor agonist that acts as regulator of appetite and thereby minimizing food intake by reducing feelings of hunger and increasing feelings of fullness and satiety. Semaglutide is a recent FDA approved medication that was initially used for diabetes and is now approved for weightloss. In research trials, participants who took Semaglutide lost an average of 6.2% to 12.4% of their initial body weight. Not only does it help with weightloss but can also lower A1C, improve cardiovasclar function, and decrease inflammation.